Compound ID | 852
EP 1350
Class: Macrolide
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae |
| Description: | Qiu Y, Jian T, Vo NH, et al. Novel 4'-O- substituted tylosin derivatives to overcome bacterial resistance. 43rd-ICAAC 2003;242 |
| Institute where first reported: | Enanta Pharmaceuticals, USA |
| Year first mentioned: | 2003 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.